Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Hepatol. Jun 27, 2019; 11(6): 531-541
Published online Jun 27, 2019. doi: 10.4254/wjh.v11.i6.531
Figure 2
Figure 2 Kaplan-Meir survival curves. A: Results from log-rank test showed significant differences in Child-Pugh A and B vs Child-Pugh C. a: Survival data of patients with Child-Pugh A and B (n = 30), b: Survival data of patients with Child-Pugh C (n = 8). Median survival time was 43 wk; B: Results from log-rank test showed no significant differences of rifaximin group vs control group. a: Survival data of rifaximin group (n = 38), b: Survival data of control group (n = 34).